Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsWorld

Indonesia approves Sinopharm COVID-19 vaccine for emergency use

No detailed efficacy data of Sinopharm's vaccine has been publicly released, but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said the vaccine was 79.34% effective in preventing people from developing the disease, based on interim data.

April 30, 2021 / 09:18 AM IST
Source: Reuters

Source: Reuters

Indonesia's drug regulator on Friday approved a COVID-19 vaccine produced by China's Sinopharm, which is due to be used in a private vaccination scheme under which companies can buy government-procured vaccines to inoculate their staff.

No detailed efficacy data of Sinopharm's vaccine has been publicly released, but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said the vaccine was 79.34% effective in preventing people from developing the disease, based on interim data.
Reuters
first published: Apr 30, 2021 09:14 am

stay updated

Get Daily News on your Browser
Sections